Step by Stepa HemeOncBuddy patient portal

Capivasertib

Illustration: Capivasertib

Say it: kap-ih-va-SER-tib · Brand names: Truqap

Capivasertib is a targeted therapy pill that blocks AKT, a protein that helps some breast cancers grow.

What it is

Some breast cancers have changes in genes called PIK3CA, AKT1, or PTEN. These changes keep a growth signal turned on through a protein called AKT. Capivasertib blocks AKT and is given with fulvestrant.

Often used for

How you get it

Capivasertib is a pill you take by mouth at home, twice a day, about 12 hours apart, with or without food. It is taken for 4 days in a row, then not taken for 3 days, each week. Your schedule may be different.

Common side effects and what helps

Call your care team right away if you have

Before you start, tell your team

Good to know

At home

Questions to ask

Side effect guides

Sources

Quick answers

What is Capivasertib?
Capivasertib is a targeted therapy pill that blocks AKT, a protein that helps some breast cancers grow. Brand names: Truqap.
What is Capivasertib used for?
hormone receptor positive, HER2 negative breast cancer with a PIK3CA, AKT1, or PTEN gene change that is advanced or has spread, given with fulvestrant.
How is Capivasertib given?
Capivasertib is a pill you take by mouth at home, twice a day, about 12 hours apart, with or without food. It is taken for 4 days in a row, then not taken for 3 days, each week. Your schedule may be different.
What are the common side effects of Capivasertib?
Diarrhea. Rash. High blood sugar. Feeling sick to your stomach or throwing up. Feeling tired or weak. Mouth sores. Throwing up.
When should I call my care team while taking Capivasertib?
Signs of high blood sugar, such as feeling very thirsty, peeing a lot, or feeling confused; Diarrhea that does not get better with the medicine your team gave you, or more than 4 to 6 loose stools in a day; A rash with blisters, peeling skin, or sores in your mouth or eyes; Feeling dizzy or faint, or not able to keep fluids down; A fever of 100.4 degrees Fahrenheit (38 degrees Celsius) or higher, or chills.

Last updated: 2026-10-27. Medically reviewed by Veli Bakalov, MD, medical oncologist (October 2026). General education from Step by Step, the patient portal of HemeOncBuddy.